Literature DB >> 10822859

Spread of resistance from food animals to man--the UK experience.

E J Threlfall1, L R Ward, J A Frost, G A Willshaw.   

Abstract

Since 1990 there have been dramatic increase in the occurrence multiply drug-resistant strains of zoonotic pathogens causing infections in humans in many developed countries. Of particular note has been the epidemic spread of MR strains of S. typhimurium DT 104, which now appear to have an almost world-wide distribution. Within DT104 the increasing spectrum of resistance is of considerable concern, with strains with decreased susceptibility to ciprofloxacin increasing in incidence in the United Kingdom and also causing serious disease in humans in other countries. For campylobacters the incidence of ciprofloxacin-resistant organisms is also increasing, with reports of such isolates from numerous countries throughout the world. For VTEC O157, although resistance is increasing, multiple resistance and resistance to ciprofloxacin remains rare. Drug resistance in food-borne pathogens is an unfortunate but almost inevitable consequence of the use of antimicrobials in food animals. Although for some pathogens--e.g., Campylobacter spp., the use of antimicrobials in human medicine is also an important factor (Smith el al 1999), it is the use of antimicrobials in food animals which has been a major factor in the development of decreased susceptibility to antibiotics such as ciprofloxacin in zoonotically-transmitted salmonellas. Such use is quite legitimate. However it is regrettable that recommendations such as propounded in 1992 in the UK by the Expert Group on Animal Feedingstuffs--the Lamming Committee, that any new antibiotics with cross resistance to those used in human medicine should not be used for prophylaxis in animal husbandry, were not accepted (Anonymous, 1992). Although the clock cannot be turned back, to combat the development of resistance to such important drugs as the fluoroquinolones it is hoped that a Code of Practice for their use in food animals will soon be internationally implemented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822859

Source DB:  PubMed          Journal:  Acta Vet Scand Suppl        ISSN: 0065-1699


  14 in total

Review 1.  Understanding the contribution of environmental factors in the spread of antimicrobial resistance.

Authors:  Stephanie Fletcher
Journal:  Environ Health Prev Med       Date:  2015-04-29       Impact factor: 3.674

2.  Characterization of antimicrobial resistant Salmonella enterica serovars Enteritidis and Typhimurium isolates from animal and food in Southern Italy.

Authors:  Anna Giannina Perugini; Maria Rosaria Carullo; Assunta Esposito; Vincenzo Caligiuri; Federico Capuano; Giorgio Galiero; Giuseppe Iovane
Journal:  Vet Res Commun       Date:  2010-04-17       Impact factor: 2.459

3.  Utilization of plant-derived recombinant human β-defensins (hBD-1 and hBD-2) for averting salmonellosis.

Authors:  Sunita Patro; Soumitra Maiti; Santosh Kumar Panda; Nrisingha Dey
Journal:  Transgenic Res       Date:  2014-11-23       Impact factor: 2.788

4.  A descriptive study of human Salmonella serotype typhimurium infections reported in Ontario from 1990 to 1998.

Authors:  Michael W Ford; Agricola Odoi; Shannon E Majowicz; Pascal Michel; Dean Middleton; Bruce Ciebin; Kathryn Doré; Scott A McEwen; Jeffery A Aramini; Shelley Deeks; Frances Jamieson; Rafiq Ahmed; Frank G Rodgers; Jeff B Wilson
Journal:  Can J Infect Dis       Date:  2003-09

5.  Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium.

Authors:  Morten Helms; Pernille Vastrup; Peter Gerner-Smidt; Kåre Mølbak
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

6.  Characterization of Salmonella enterica serotype Typhimurium isolates from human, food, and animal sources in the Republic of Ireland.

Authors:  Rachel Gorman; Catherine C Adley
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  International Salmonella Typhimurium DT104 infections, 1992-2001.

Authors:  Morten Helms; Steen Ethelberg; Kåre Mølbak
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

8.  In Vitro and In Vivo Antibacterial Activity of Punica granatum Peel Ethanol Extract against Salmonella.

Authors:  Jang-Gi Choi; Ok-Hwa Kang; Young-Seob Lee; Hee-Sung Chae; You-Chang Oh; Obiang-Obounou Brice; Min-San Kim; Dong-Hwan Sohn; Hun-Soo Kim; Hyun Park; Dong-Won Shin; Jung-Rae Rho; Dong-Yeul Kwon
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-12       Impact factor: 2.629

9.  Antibiotics in animal feed and spread of resistant Campylobacter from poultry to humans.

Authors:  Nicole M Iovine; Martin J Blaser
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

10.  Campylobacter antimicrobial drug resistance among humans, broiler chickens, and pigs, France.

Authors:  Anne Gallay; Valérie Prouzet-Mauléon; Isabelle Kempf; Philippe Lehours; Leila Labadi; Christine Camou; Martine Denis; Henriette de Valk; Jean-Claude Desenclos; Francis Mégraud
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.